Proof-of-Concept Trial of Oral VH4011499 (VH-499), a New HIV-1 Capsid Inhibitor

Category Primary study
Conference2025 Conference on Retroviruses and Opportunistic Infections, CROI 2025
Year 2025
This article has no abstract
Epistemonikos ID: 1143ffc8f0613d08925768c6b9504b82ba1cb343
First added on: Jun 15, 2026